INS and Hypoglycemia: These inhibitors have certain advantages as oral hypoglycemic agents, such as weight neutrality, less risk of hypoglycemia, and an insulin-independent mechanism of action as an oral hypoglycemic agent, when compared with other drugs, such as sulfonylureas [49].